Covered recipient · General Payments record
ROBIN DALAL
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$21,298.54
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,000.00 | 2 |
| Travel and Lodging | $2,449.87 | 6 |
| Food and Beverage | $365.66 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $9,606.58 | 15 |
| Janssen Biotech, Inc. | $169.80 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.15 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529917 | CMS |
| ABBVIE INC. | $23.03 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529919 | CMS |
| ABBVIE INC. | $581.09 | 06/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182556 | CMS |
| ABBVIE INC. | $164.00 | 06/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182558 | CMS |
| ABBVIE INC. | $495.40 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182560 | CMS |
| ABBVIE INC. | $159.00 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182562 | CMS |
| ABBVIE INC. | $17.82 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529921 | CMS |
| ABBVIE INC. | $85.00 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182564 | CMS |
| ABBVIE INC. | $965.38 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182566 | CMS |
| ABBVIE INC. | $5,600.00 | 07/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133381 | CMS |
| ABBVIE INC. | $17.12 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529923 | CMS |
| ABBVIE INC. | $24.87 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529925 | CMS |
| ABBVIE INC. | $9.69 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529927 | CMS |
| ABBVIE INC. | $34.76 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103529929 | CMS |
| ABBVIE INC. | $1,400.00 | 09/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133383 | CMS |
| Janssen Biotech, Inc. | $143.06 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078674459 | CMS |
| Janssen Biotech, Inc. | $26.74 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078672785 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.00 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137523250 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.15 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137523253 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.